Structures by: Sethuraman V.
Total: 9
(3<i>S</i>,5<i>R</i>,6<i>S</i>)-Diphenylmethyl 1-oxo-6-bromopenicillanate
C21H20BrNO4S
IUCrData (2020) 5, 2 x200143
a=11.076(2)Å b=11.076(2)Å c=16.478(3)Å
α=90.00° β=90.00° γ=90.00°
Trimethoprim p-toluenesulfonate
C21H26N4O6S
CrystEngComm (2003) 5, 15 70
a=13.407(3)Å b=10.039(3)Å c=17.115(7)Å
α=90.00° β=90.60(3)° γ=90.00°
Trimethoprim sulfanilate monohydrate
C20H27N5O7S
CrystEngComm (2003) 5, 15 70
a=17.855(4)Å b=6.136(10)Å c=21.349(4)Å
α=90.00° β=109.080(3)° γ=90.00°
(2,4-diamino-5-(3',4',5'-trimethoxybenzyl)pyrimidinium) benzenesulfonate, monohydrate.
(C14H19N4O3),(C6H5SO3).H20
CrystEngComm (2003) 5, 15 70
a=17.507(2)Å b=6.323(3)Å c=21.350(2)Å
α=90.00° β=107.80(2)° γ=90.00°
2,4-diamino-5-(3',4',5'-trimethoxybenzyl)pyrimidinium 3- carboxy-4-hydroxybenzene sulfonate dihydrate
C14H19N4O3,C7H5O6S,2H2O
CrystEngComm (2003) 5, 15 70
a=11.442(2)Å b=18.769(3)Å c=12.783(3)Å
α=90.00° β=114.18(3)° γ=90.00°
2,4-Diamino-6-oxo-3,6-dihydropyrimidin-1-ium <i>p</i>-toluenesulfonate
C4H7N4O1,C7H7O3S1
Acta Crystallographica Section E (2015) 71, 5 476-478
a=30.8628(7)Å b=6.5559(2)Å c=13.1565(3)Å
α=90° β=96.4280(10)° γ=90°
Pyrimethamine
C12H13ClN4
Acta Crystallographica Section E (2002) 58, 8 o817-o818
a=9.5854(15)Å b=10.8061(17)Å c=12.484(2)Å
α=79.059(13)° β=89.440(15)° γ=82.372(14)°
Diaquadinitratothiabendazolecopper(II)
C10H11CuN5O8S
Acta Crystallographica Section E (2002) 58, 8 m392-m395
a=7.580(4)Å b=20.065(5)Å c=10.606(2)Å
α=90° β=109.51(3)° γ=90°
1-[2-(Dimethylazaniumyl)ethyl]-1<i>H</i>-1,2,3,4-tetrazole-5-thiolate
C5H11N5S
Acta Crystallographica Section E (2014) 70, 2 o224
a=7.10210(10)Å b=11.2476(2)Å c=10.7045(2)Å
α=90° β=102.4790(10)° γ=90°